KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Return on Capital Employed (2016 - 2026)

Bristol Myers Squibb has reported Return on Capital Employed over the past 17 years, most recently at 6.84% for Q1 2026.

  • Quarterly Return on Capital Employed rose 479.0% to 6.84% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 6.84% through Mar 2026, up 479.0% year-over-year, with the annual reading at 6.79% for FY2025, 2509.0% up from the prior year.
  • Return on Capital Employed was 6.84% for Q1 2026 at Bristol Myers Squibb, down from 6.58% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 1.88% in Q1 2023 and troughed at 32.22% in Q4 2024.
  • The 5-year median for Return on Capital Employed is 6.58% (2025), against an average of 10.25%.
  • Year-over-year, Return on Capital Employed plummeted -2904bps in 2024 and then surged 2564bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 3.21% in 2022, then grew by 1bps to 3.18% in 2023, then tumbled by -915bps to 32.22% in 2024, then soared by 80bps to 6.58% in 2025, then dropped by -4bps to 6.84% in 2026.
  • Per Business Quant, the three most recent readings for BMY's Return on Capital Employed are 6.84% (Q1 2026), 6.58% (Q4 2025), and 9.78% (Q3 2025).